No adverse effects were reported in the breastfed infants
As compounded GLP-1 programs become more widely discussed across the market, and as pricing transparency becomes a key factor for prospective patients, platforms like IVY Rx are drawing attention for their flat-rate monthly structure and direct-to-consumer model
Moreover, improvements in cardiac function resulting from treatment with GLP-1 receptor agonists may also contribute to the favorable kidney outcomes seen with these treatments by improving tissue perfusion (20)
However, experts such as Lydia Alexander, MD, president of the Obesity Medicine Association (OMA) and Chief Medical Officer at Enara, argue that the risks of compounded peptide medications make them a dangerous alternative to approved GLP-1 drugs as they are often produced and sold illegally by unlicensed pharmacies and "bootleggers" taking advantage of drug shortages, potentially containing unknown or dangerous ingredients that could be ineffective or actively harmful to patients
The FDA (Food and Drug Administration) protects the safety of medications in the U.S
The decreasing efficacy of antibiotics has put pressure on medical professionals and researchers to focus efforts on developing alternative treatments for S
